The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 24, 2013
Filed:
Aug. 19, 2009
Cecil D. Kwong, Birmingham, AL (US);
F. George Njoroge, Warren, NJ (US);
Subramaniam Ananthan, Birmingham, AL (US);
Ashok Arasappan, Bridgewater, NJ (US);
Frank Bennett, Cranford, NJ (US);
Jeremy Clark, Birmingham, AL (US);
Anita T. Fowler, Irondale, AL (US);
Feng Geng, Piscataway, NJ (US);
Hollis S. Kezar, Iii, Hoover, AL (US);
Joseph A. Maddry, Birmingham, AL (US);
John J. Piwinski, Lebanon, NJ (US);
Robert C. Reynolds, Birmingham, AL (US);
Abhijit Roychowdhury, Birmingham, AL (US);
John A. Secrist, Iii, Birmingham, AL (US);
Neng-yang Shih, Lexington, MA (US);
Cecil D. Kwong, Birmingham, AL (US);
F. George Njoroge, Warren, NJ (US);
Subramaniam Ananthan, Birmingham, AL (US);
Ashok Arasappan, Bridgewater, NJ (US);
Frank Bennett, Cranford, NJ (US);
Jeremy Clark, Birmingham, AL (US);
Anita T. Fowler, Irondale, AL (US);
Feng Geng, Piscataway, NJ (US);
Hollis S. Kezar, III, Hoover, AL (US);
Joseph A. Maddry, Birmingham, AL (US);
John J. Piwinski, Lebanon, NJ (US);
Robert C. Reynolds, Birmingham, AL (US);
Abhijit Roychowdhury, Birmingham, AL (US);
John A. Secrist, III, Birmingham, AL (US);
Neng-Yang Shih, Lexington, MA (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Southern Research Institute, Birmingham, AL (US);
Abstract
The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R, X, Y, Z, R, R, R, R, R, R, R, R, R, Rand n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.